Inhibition of NF-kB/DNA Interactions and HIV-1 LTR Directed Transcription by Hybrid Molecules Containing Pyrrolo [2,1-c] [1,4] Benzodiazepine (PBD) and Oligopyrrole Carriers-Reference-Cited by-同舟云学术

Inhibition of NF-kB/DNA Interactions and HIV-1 LTR Directed Transcription by Hybrid Molecules Containing Pyrrolo [2,1-c] [1,4] Benzodiazepine (PBD) and Oligopyrrole Carriers

Published:2003-10-03 Issue:3 Volume:60 Page:173-185
ISSN:0272-4391
Container-title:Drug Development Research
language:en
Short-container-title:Drug Dev. Res.

Author:

Borgatti Monica,Rutigliano Cristina,Bianchi Nicoletta,Mischiati Carlo,Baraldi Pier Giovanni,Romagnoli Romeo,Gambari Roberto

Publisher

Wiley

Subject

Drug Discovery

Reference27 articles.

1. Structure and Synthesis of Distamycin A

2. Design, synthesis and biological activity of a pyrrolo [2,1-c][1,4]benzodiazepine (PBD)-distamycin hybrid

3. Synthesis, in Vitro Antiproliferative Activity, and DNA-Binding Properties of Hybrid Molecules Containing Pyrrolo[2,1-c][1,4]benzodiazepine and Minor-Groove-Binding Oligopyrrole Carriers

4. [2,1-c] [1,4]Benzodiazepine (PBD)-Distamycin Hybrid Inhibits DNA Binding to Transcription Factor Sp1

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of Systematic Shortening of Noncovalent C8 Side Chain on the Cytotoxicity and NF-κB Inhibitory Capacity of Pyrrolobenzodiazepines (PBDs);Journal of Medicinal Chemistry;2019-01-28

2. Synthetic Strategies toward Bioactive Compounds for Chemotherapy: From Natural Products to Hybrid Strategy;KAGAKU TO SEIBUTSU;2017-06-20

3. GC-Targeted C8-Linked Pyrrolobenzodiazepine–Biaryl Conjugates with Femtomolar in Vitro Cytotoxicity and in Vivo Antitumor Activity in Mouse Models;Journal of Medicinal Chemistry;2013-03-21

4. Hybrid molecules between distamycin A and active moieties of antitumor agents;Bioorganic & Medicinal Chemistry;2007-01

5. Design, Synthesis, and Biophysical and Biological Evaluation of a Series of Pyrrolobenzodiazepine−Poly(N-methylpyrrole) Conjugates;Journal of Medicinal Chemistry;2006-08-05